Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
12/2003
12/04/2003WO2003008604A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated aceb gene
12/04/2003WO2003008540A3 Abiotic stress responsive polynucleotides and polypeptides
12/04/2003WO2003000904A3 Identification and characterization of plant genes
12/04/2003WO2003000897A3 Identification and characterization of phosphate transporter genes
12/04/2003WO2003000880A3 Homoaconitase as a target for fungicides
12/04/2003WO2002102310A3 Proteins associated with cell growth, differentiation, and death
12/04/2003WO2002086138A3 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent
12/04/2003WO2002083892A3 Mutants of desoxycytidine kinase having extended enzymatic activity
12/04/2003WO2002083887A3 Regulation of human methionine aminopeptidase-like protein
12/04/2003WO2002083861A3 A phospholipid transporting atpase molecule and uses therefor
12/04/2003WO2002081626A3 D-hydantoinase from ochrobactrum anthropi
12/04/2003WO2002081510A3 Proteins, polynucleotides encoding them and methods of using the same
12/04/2003WO2002080846A3 Epothilone derivatives and methods for making and using the same
12/04/2003WO2002074974A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
12/04/2003WO2002074970A8 A process for the production of an inhibitor of human platelet aggregation and soybean lipoxygenase
12/04/2003WO2002070723A3 Maize peroxidase genes and their use for improving plant disease resistance and stalk strength
12/04/2003WO2001050829A3 Alzheimer's disease secretase, app substrates therefor, and uses therefor
12/04/2003US20030226179 Comprises nucleotide sequences coding enzymatic polypeptide for detecting herbicides; designing herbicide resistant plants
12/04/2003US20030226177 Dwarfism genes and dwarf plants
12/04/2003US20030226175 Comprises nucleotide sequences coding polypeptides which control fruit ripening in bananas; bioreactors for expressing heterologous therapeutic proteins
12/04/2003US20030226166 Comprises expression vector coding regulatory sequences for efficient expression of heterologous polypeptides which confer herbicide, disease and insect resistance in plants; improved stability or shelf life
12/04/2003US20030226164 Using recombinase to obtain site-specific recombination of DNA within dicotyledonous and monocotyledonous plant cells
12/04/2003US20030226163 Preparing trangenic cells which comprise 3-hydroxy-3-methylglutaryl CoA reductase regulatory sequences for use in expression of heterologous polypeptides; biological pest control; bioreactors
12/04/2003US20030226162 Genetically engineered woody plants with enhanced glucosyltransferase activity; papermaking
12/04/2003US20030226161 Salutaridinol 7-O-acetyltransferase and derivatives thereof
12/04/2003US20030226160 Compositions and methods for locating preferred integration sites within the genome of a plant
12/04/2003US20030226158 Cds1 knockout cells and mice, and their utilization
12/04/2003US20030225527 Crystals and structures of MST3
12/04/2003US20030225259 Novel human kinase and polynucleotides encoding the same
12/04/2003US20030225258 Novel human proteases and polynucleotides encoding the same
12/04/2003US20030225257 Comprises nucleotide sequences coding enzymatic polypeptides for use as drug screening, diagnostic and therapeutic tools; cosmetics; nutriceuticals
12/04/2003US20030225256 Antisense modulation of pctaire protein kinase 2 expression
12/04/2003US20030225253 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/04/2003US20030225027 Used to reduce resistance of cancer cells to treatment with an anticancer drug that generates oxidative stress
12/04/2003US20030225026 Inhibiting receptor-type tyrosine phosphatase epsilon activity or expression in tumor cells
12/04/2003US20030225017 Chlamydia antigens and corresponding DNA fragments and uses thereof
12/04/2003US20030225006 Novel spinosyn-producing polyketide synthases
12/04/2003US20030224985 Enhanced resistance to TS-inhibiting drugs like 5-fluorouracil or 5-fluoro-2-deoxyuridinemonophosphate.
12/04/2003US20030224970 Methods for the identification of inhibitors of S-adenosylmethionine decarboxylase as antibiotics
12/04/2003US20030224969 Specific nucleotides or proteins encoded thereby are used in assays to identify inhibitors of human analogs of murine hematopoetic-specific, cytokine-inducible deubiquinating proteases
12/04/2003US20030224968 Identifying subjects who have or are at risk for developing Hereditary Spastic Paraplegia by detecting the presence or absence of one or more variations in the atlastin gene or treating HSP by administering atlastin
12/04/2003US20030224509 DAP-kinase and HOXA9, two human genes associated with genesis, progression, and aggressiveness of non-small cell lung cancer
12/04/2003US20030224501 Bone morphogenic protein polynucleotides, polypeptides, and antibodies
12/04/2003US20030224500 Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereof
12/04/2003US20030224499 Comprises nucleotide sequences coding phosphotransferase subunit for fermentation of lysine; animal feeds; medicines; human nutrients
12/04/2003US20030224498 Comprises nucleotide sequences coding serpin domains for diagnosis and treatment of metabolic and infectious disorders; enzyme inhibitors; cosmetic or nutriceutical; drug screening
12/04/2003US20030224495 Synthesis performed in enantiomer-pure form with chorismate by cultivation of genetically altered non-pathogenic organism which has aromate embolism and increased activity of isochorismate synthase and isochorismatase
12/04/2003US20030224494 Polyhydroxyalkanoate-containing structure and manufacturing method thereof
12/04/2003US20030224493 Comprises genetically engineered biooxidation enzyme for conversion of oleic acid into a 18-carbon dicarboxylic acid
12/04/2003US20030224491 Continuous fermentation process
12/04/2003US20030224490 Fusion partner cells and uses thereof
12/04/2003US20030224489 Plasmid for transformation and expression of chymosin nucleotide sequences in aspergillus
12/04/2003US20030224483 Control of gene expression in eukaryotic cells
12/04/2003US20030224482 Heterologous polypeptides expressed in filamentous fungi, processes for making same, and vectors for making same
12/04/2003US20030224476 Enhancing transglutaminase reactivity for use in food processing and flavor improvement
12/04/2003US20030224461 Nucleic acids, proteins, and antibodies
12/04/2003US20030224460 Novel compositions and methods for lymphoma and leukemia
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224432 Preparing small interfering RNAs for use as tools in determining gene function
12/04/2003US20030224430 Regulation of human eosinophil serine protease 1-like enzyme
12/04/2003US20030224417 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors
12/04/2003US20030224414 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders
12/04/2003US20030224396 Regulation of human aminotransferase-like enzyme
12/04/2003US20030224378 Novel human protein kinases and protein kinase-like enzymes
12/04/2003US20030224376 Novel human transferase family members and uses thereof
12/04/2003US20030224368 Crystallizable compositions comprising a caspase-7
12/04/2003US20030224367 Novel polypeptides and nucleic acids encoding same
12/04/2003US20030224364 Compositions and methods for identifying and distinguishing orthosomycin biosynthetic loci
12/04/2003US20030224358 Comprises nucleotide sequences coding membrane protein for use as anticarcinogenic/antitumor/antiinflammatory agent
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/04/2003US20030224013 Methods for protection against Coccidioides spp. infection using Coccidioides spp. urea amidohydrolase (Ure) protein
12/04/2003US20030224009 An expression vector containing a promoter co-dependently regulatable by cyclic AMP and anaerobiosis, capable of at least one: being chromosomally integrated in bacterial cell, and being maintained extrachromosomally in a bacterial cell
12/04/2003US20030224007 A protective protein in the form of vaccine, containing a polypeptide from a pro-region of a cathepsin L protease obtained from excretory/secretory products of newly excysted juvenile stages of Fasciola hepatical
12/04/2003US20030224003 Administering to a mammal a preparation containing a portion of the amino acid sequence of mature adenylate cyclase of a second Bordetella species for immunizing the mammal against infection by a first Bordetella species
12/04/2003US20030223984 Isolated from the genus Carica are provided. In particular the proteases are cysteine proteases isolated from Carica candamarcensis. In addition, the recombinant forms of the protease, including fragments and mutants with substantial
12/04/2003US20030223981 Peptide inhibitors of protein kinase C gamma for pain management
12/04/2003US20030223979 Therapeutic method for treating patients with acute intermittent porphyria (AIP) and other porphyric diseases
12/04/2003US20030223976 Control sequences of the human corin gene
12/04/2003US20030223973 Discloses the protease stratum corneum chymotrytic enzyme (SCCE) is specifically over-expressed in ovarian and other malignancies. A number of SCCE peptides can induce immune responses to SCCE, thereby demonstrating the potential of
12/04/2003US20030223966 Treatment for pompe disease
12/04/2003US20030223963 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders
12/04/2003CA2487303A1 Assays for modulators of asparaginyl hydroxylase
12/04/2003CA2487243A1 Transformed fungi for production of recombinant proteins
12/04/2003CA2487143A1 Regulation of novel human asparagine-hydroxylases
12/04/2003CA2486619A1 Methods and materials for treating inflammatory conditions
12/04/2003CA2486615A1 Low molecular weight protein tyrosine phosphatase (lmw-ptp) as a diagnostic and therapeutic target
12/04/2003CA2486559A1 Fatty acid desaturases from fungi
12/04/2003CA2486408A1 Methods and compositions for regulation and manipulation of steroidogenesis
12/04/2003CA2485829A1 Methods and constructs for high yield expression of clostripain
12/04/2003CA2485182A1 Plant thymidine kinases and their use
12/03/2003EP1367127A1 A method for production of plants with suppressed photorespiration and improved CO2 fixation
12/03/2003EP1367123A1 Neurotonin and use thereof
12/03/2003EP1367120A2 Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366180A2 Use of mutations of mec-1 and its related genes in the identification of compounds for treatment of disease
12/03/2003EP1366176A2 Synthetic genes and bacterial plasmids devoid of cpg
12/03/2003EP1366175A2 Multifunctional protease inhibitors and their use in treatment of disease
12/03/2003EP1366173A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
12/03/2003EP1366172A1 Nucleic acids coding for a protein interacting with a porin channel
12/03/2003EP1366164A1 Nucleic acid expressed in the hypothalamus or muscle tissue in obese animals